Search research articles
Contact Us
Filters
Showing results (141-150 of 149) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 149 results.
Journal of Medicinal Chemistry
|
February 14, 2018
High-Affinity Peptidomimetic Inhibitors of the DCN1-UBC12 Protein-Protein Interaction
Haibin Zhou, Weihua Zhou, Bing Zhou, et al.
The Journal of Allergy and Clinical Immunology
|
May 22, 2024
IL-4-STAT6 axis amplifies histamine-induced vascular endothelial dysfunction and hypovolemic shock
James Krempski, Amnah Yamani, Lakshmi Narasimha Rao Thota, et al.
Journal of Medicinal Chemistry
|
November 7, 2024
Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression
Renqi Xu, Haibin Zhou, Longchuan Bai, et al.
Cancer Cell
|
November 13, 2019
A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
Longchuan Bai, Haibin Zhou, Renqi Xu, et al.
Journal of Medicinal Chemistry
|
November 21, 2019
Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein
Haibin Zhou, Longchuan Bai, Renqi Xu, et al.
The Journal of Allergy and Clinical Immunology
|
August 31, 2023
IL-13-induced STAT3-dependent signaling networks regulate esophageal epithelial proliferation in eosinophilic esophagitis
Sahiti Marella, Ankit Sharma, Varsha Ganesan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 1, 2026
BCR::ABL1-Induced Enhancer Reprogramming Uncovers Hypersensitivity of Ph+B-ALL Cells to Enhancer-Targeting Drugs
Han Leng Ng, Trudy Lee Glaser, Jintao Zhu, et al.
Leukemia
|
August 30, 2024
IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma
Jennifer Sun, Stefan Corradini, Feda Azab, et al.
Nature
|
May 14, 2025
STAT5 and STAT3 balance shapes dendritic cell function and tumour immunity
Jiajia Zhou, Kole Tison, Haibin Zhou, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 149) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 149 results.
Journal of Medicinal Chemistry
|
February 14, 2018
High-Affinity Peptidomimetic Inhibitors of the DCN1-UBC12 Protein-Protein Interaction
Haibin Zhou, Weihua Zhou, Bing Zhou, et al.
The Journal of Allergy and Clinical Immunology
|
May 22, 2024
IL-4-STAT6 axis amplifies histamine-induced vascular endothelial dysfunction and hypovolemic shock
James Krempski, Amnah Yamani, Lakshmi Narasimha Rao Thota, et al.
Journal of Medicinal Chemistry
|
November 7, 2024
Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression
Renqi Xu, Haibin Zhou, Longchuan Bai, et al.
Cancer Cell
|
November 13, 2019
A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
Longchuan Bai, Haibin Zhou, Renqi Xu, et al.
Journal of Medicinal Chemistry
|
November 21, 2019
Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein
Haibin Zhou, Longchuan Bai, Renqi Xu, et al.
The Journal of Allergy and Clinical Immunology
|
August 31, 2023
IL-13-induced STAT3-dependent signaling networks regulate esophageal epithelial proliferation in eosinophilic esophagitis
Sahiti Marella, Ankit Sharma, Varsha Ganesan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 1, 2026
BCR::ABL1-Induced Enhancer Reprogramming Uncovers Hypersensitivity of Ph+B-ALL Cells to Enhancer-Targeting Drugs
Han Leng Ng, Trudy Lee Glaser, Jintao Zhu, et al.
Leukemia
|
August 30, 2024
IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma
Jennifer Sun, Stefan Corradini, Feda Azab, et al.
Nature
|
May 14, 2025
STAT5 and STAT3 balance shapes dendritic cell function and tumour immunity
Jiajia Zhou, Kole Tison, Haibin Zhou, et al.
Page
of 15